Clinical Trial

Trial of JMKX003801 in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 26, 2024 (before its estimated May 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
To Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of JMKX003801 Administered Randomly, Double-blind, Placebo-controlled, Single-ascending Dose and Multiple-ascending Dose in Chinese Healthy Adult Participants
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-08; most recent amendment 2024-09-24.
Status change: Not Yet Recruiting → Recruiting 2024-09-24
Trial Details
NCT Number NCT06549309
Lead Sponsor Jemincare
Conditions Healthy
Enrollment 70 participants
Start Date 2024-08-17
Primary Completion 2025-05-31 (estimated)
Study Completion 2025-06-12 (estimated)
Updated on ClinicalTrials.gov 2024-09-26